Figures & data
Table 1. Patient characteristics.
Figure 2. Overall survival for patients treated with chemoradiotherapy or chemoradiotherapy plus hyperthermia.
![Figure 2. Overall survival for patients treated with chemoradiotherapy or chemoradiotherapy plus hyperthermia.](/cms/asset/8c7035a5-b5b9-4c20-bf2c-62dcd0edb999/ihyt_a_1213430_f0002_b.jpg)
Figure 3. Disease-free survival for patients treated with chemoradiotherapy or chemoradiotherapy plus hyperthermia.
![Figure 3. Disease-free survival for patients treated with chemoradiotherapy or chemoradiotherapy plus hyperthermia.](/cms/asset/771fe71f-78e9-4fcd-9fbd-dd9732244ba0/ihyt_a_1213430_f0003_b.jpg)
Figure 4. Local relapse-free survival for patients treated with chemoradiotherapy or chemoradiotherapy plus hyperthermia.
![Figure 4. Local relapse-free survival for patients treated with chemoradiotherapy or chemoradiotherapy plus hyperthermia.](/cms/asset/aadbf091-31f3-48dd-80ad-02d53167049e/ihyt_a_1213430_f0004_b.jpg)
Figure 5. Result of logistic regression analysis to predict complete response (adjusted for age, stage and histology).
![Figure 5. Result of logistic regression analysis to predict complete response (adjusted for age, stage and histology).](/cms/asset/2845f5f5-aa1e-4211-97e7-2c7fa55c84fd/ihyt_a_1213430_f0005_b.jpg)
Table 2. Acute-phase adverse events.
Table 3. Late-phase adverse events.